Sinovac Biotech (NASDAQ: SVA) extends US$55.00 special cash dividend instruction deadline
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Sinovac Biotech Ltd. is extending the deadline for shareholders and nominee brokers to submit payment instructions for its previously declared special cash dividend of US$55.00 per common share. The dividend is payable to valid holders of common shares as of the close of business on May 23, 2025.
The original instruction submission deadline of December 31, 2025 has been pushed back to June 30, 2026, giving eligible holders more time to complete the required materials so they can receive the dividend.
Positive
- None.
Negative
- None.
Key Figures
Special cash dividend: US$55.00 per common share
Record date for dividend: May 23, 2025
Original instruction deadline: December 31, 2025
+1 more
4 metrics
Special cash dividend
US$55.00 per common share
Previously declared dividend amount
Record date for dividend
May 23, 2025
Close of business ET for valid holders
Original instruction deadline
December 31, 2025
Initial cutoff for submitting payment instructions
Extended instruction deadline
June 30, 2026
New cutoff for submitting payment instructions
Key Terms
special cash dividend, record date, Information Agent, biopharmaceutical, +1 more
5 terms
special cash dividend financial
"previously announced a special cash dividend of US$55.00 per common share"
A special cash dividend is a one-time, extra cash payment a company gives to its shareholders in addition to its regular dividends, like a bonus check sent out when a business has more cash than usual. It matters to investors because it delivers immediate cash value, can signal that the company has strong short-term cash or limited opportunities to reinvest, and typically reduces the company’s cash reserves and may affect the stock price and tax treatment for recipients.
record date financial
"payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
Information Agent financial
"If you have any questions ... please contact the Information Agent D.F. King & Co., Inc."
An information agent is a person, team, or third-party service designated to collect, verify and distribute a company’s important announcements, filings or notices to regulators, shareholders and the public. Think of it as the company’s official mailroom and translator combined—responsible for making sure the right facts get to the right people quickly and accurately; investors watch who serves this role because mistakes or delays can affect compliance, market reaction and trust.
biopharmaceutical financial
"a leading provider of biopharmaceutical products in China"
A biopharmaceutical is a medicine made from living organisms or their components—such as proteins, cells or genetic material—rather than chemically synthesized compounds. For investors, these products can command high prices and long patent protection but also carry bigger development, manufacturing and regulatory risks; think of them like handcrafted, high-tech products that can generate strong returns if they work, but are costly and complex to produce.
prequalified by WHO financial
"3 vaccines have been prequalified by WHO, including inactivated hepatitis A vaccine Healive"
FAQ
What did Sinovac Biotech Ltd. (SVA) announce in this 6-K filing?
Sinovac Biotech Ltd. announced an extension of the deadline to submit payment instructions for its previously declared special cash dividend of US$55.00 per common share. This change affects how long eligible shareholders have to complete the required documentation.
Who is eligible to receive Sinovac (SVA)’s special cash dividend?
The dividend is payable to valid holders of Sinovac’s common shares as of the close of business on May 23, 2025 ET. Eligibility is tied to share ownership on that record date, not to when instructions are later submitted.
What deadline did Sinovac (SVA) extend for its special cash dividend instructions?
Sinovac extended the deadline for submitting payment instruction materials from December 31, 2025 to June 30, 2026. Shareholders and nominee brokers now have additional time to complete and submit forms needed to receive the dividend payment.
What type of company is Sinovac Biotech Ltd. (SVA)?
Sinovac Biotech Ltd. is a China-based global biopharmaceutical company focused on vaccines and related biological products for human infectious diseases, including influenza, hepatitis, polio, varicella, HFMD, and COVID-19, with several vaccines prequalified by the World Health Organization.